Fluorine in PDB 6gfy: Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A)
Protein crystallography data
The structure of Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A), PDB code: 6gfy
was solved by
M.S.Gadd,
A.Testa,
A.Ciulli,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.36 /
2.70
|
Space group
|
P 41 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
94.115,
94.115,
367.972,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.9 /
25.8
|
Other elements in 6gfy:
The structure of Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A) also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A)
(pdb code 6gfy). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A), PDB code: 6gfy:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 6gfy
Go back to
Fluorine Binding Sites List in 6gfy
Fluorine binding site 1 out
of 4 in the Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F301
b:32.0
occ:1.00
|
FAJ
|
C:EXH301
|
0.0
|
32.0
|
1.0
|
CBD
|
C:EXH301
|
1.3
|
31.9
|
1.0
|
CBC
|
C:EXH301
|
2.3
|
32.2
|
1.0
|
CBF
|
C:EXH301
|
2.4
|
33.2
|
1.0
|
OAI
|
C:EXH301
|
2.6
|
30.3
|
1.0
|
CAW
|
C:EXH301
|
3.1
|
33.0
|
1.0
|
O
|
C:HIS110
|
3.1
|
35.8
|
1.0
|
CZ2
|
C:TRP117
|
3.2
|
29.1
|
1.0
|
CA
|
C:SER111
|
3.2
|
31.0
|
1.0
|
CB
|
C:SER111
|
3.3
|
28.1
|
1.0
|
OG
|
C:SER111
|
3.3
|
26.1
|
1.0
|
NAS
|
C:EXH301
|
3.4
|
31.5
|
1.0
|
NBG
|
C:EXH301
|
3.5
|
34.1
|
1.0
|
CAQ
|
C:EXH301
|
3.5
|
32.8
|
1.0
|
C
|
C:HIS110
|
3.8
|
36.8
|
1.0
|
N
|
C:SER111
|
3.8
|
34.1
|
1.0
|
CAK
|
C:EXH301
|
3.9
|
37.8
|
1.0
|
CD1
|
C:ILE109
|
3.9
|
38.3
|
1.0
|
CH2
|
C:TRP117
|
3.9
|
29.8
|
1.0
|
OAG
|
C:EXH301
|
3.9
|
32.5
|
1.0
|
CE2
|
C:TRP117
|
4.3
|
28.2
|
1.0
|
C
|
C:SER111
|
4.5
|
30.9
|
1.0
|
CAP
|
C:EXH301
|
4.6
|
33.5
|
1.0
|
NE1
|
C:TRP117
|
4.6
|
28.5
|
1.0
|
CAZ
|
C:EXH301
|
4.6
|
37.3
|
1.0
|
CAM
|
C:EXH301
|
4.6
|
36.7
|
1.0
|
OH
|
C:TYR98
|
4.7
|
30.8
|
1.0
|
C
|
C:EXH301
|
4.7
|
32.9
|
1.0
|
CE2
|
C:TYR98
|
4.9
|
31.8
|
1.0
|
N
|
C:TYR112
|
5.0
|
31.4
|
1.0
|
CZ
|
C:TYR98
|
5.0
|
31.0
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 6gfy
Go back to
Fluorine Binding Sites List in 6gfy
Fluorine binding site 2 out
of 4 in the Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:F301
b:35.5
occ:1.00
|
FAJ
|
F:EXH301
|
0.0
|
35.5
|
1.0
|
CBD
|
F:EXH301
|
1.3
|
33.9
|
1.0
|
CBC
|
F:EXH301
|
2.4
|
33.2
|
1.0
|
CBF
|
F:EXH301
|
2.4
|
36.0
|
1.0
|
OAI
|
F:EXH301
|
2.7
|
29.7
|
1.0
|
CAW
|
F:EXH301
|
3.1
|
36.0
|
1.0
|
CZ2
|
F:TRP117
|
3.2
|
31.0
|
1.0
|
O
|
F:HIS110
|
3.3
|
32.8
|
1.0
|
OG
|
F:SER111
|
3.3
|
27.1
|
1.0
|
NAS
|
F:EXH301
|
3.3
|
36.2
|
1.0
|
CA
|
F:SER111
|
3.4
|
29.9
|
1.0
|
CB
|
F:SER111
|
3.4
|
28.1
|
1.0
|
NBG
|
F:EXH301
|
3.5
|
36.3
|
1.0
|
CAQ
|
F:EXH301
|
3.6
|
33.3
|
1.0
|
CAK
|
F:EXH301
|
3.8
|
39.6
|
1.0
|
CH2
|
F:TRP117
|
3.9
|
31.2
|
1.0
|
C
|
F:HIS110
|
4.0
|
33.3
|
1.0
|
OAG
|
F:EXH301
|
4.0
|
32.3
|
1.0
|
N
|
F:SER111
|
4.0
|
31.3
|
1.0
|
CD1
|
F:ILE109
|
4.1
|
32.0
|
1.0
|
CE2
|
F:TRP117
|
4.2
|
29.6
|
1.0
|
CAP
|
F:EXH301
|
4.6
|
39.0
|
1.0
|
CAZ
|
F:EXH301
|
4.6
|
41.7
|
1.0
|
NE1
|
F:TRP117
|
4.6
|
29.3
|
1.0
|
CAM
|
F:EXH301
|
4.6
|
39.5
|
1.0
|
OH
|
F:TYR98
|
4.7
|
32.5
|
1.0
|
C
|
F:SER111
|
4.7
|
30.6
|
1.0
|
C
|
F:EXH301
|
4.7
|
35.4
|
1.0
|
CE2
|
F:TYR98
|
4.8
|
31.4
|
1.0
|
CZ
|
F:TYR98
|
4.8
|
31.4
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 6gfy
Go back to
Fluorine Binding Sites List in 6gfy
Fluorine binding site 3 out
of 4 in the Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:F301
b:33.5
occ:1.00
|
FAJ
|
I:EXH301
|
0.0
|
33.5
|
1.0
|
CBD
|
I:EXH301
|
1.4
|
35.0
|
1.0
|
CBC
|
I:EXH301
|
2.4
|
34.3
|
1.0
|
CBF
|
I:EXH301
|
2.4
|
36.7
|
1.0
|
OAI
|
I:EXH301
|
2.6
|
30.1
|
1.0
|
CAW
|
I:EXH301
|
3.1
|
37.5
|
1.0
|
OG
|
I:SER111
|
3.2
|
28.3
|
1.0
|
O
|
I:HIS110
|
3.2
|
32.1
|
1.0
|
CB
|
I:SER111
|
3.3
|
29.7
|
1.0
|
CA
|
I:SER111
|
3.3
|
31.8
|
1.0
|
NAS
|
I:EXH301
|
3.3
|
35.4
|
1.0
|
CZ2
|
I:TRP117
|
3.3
|
25.9
|
1.0
|
NBG
|
I:EXH301
|
3.6
|
35.8
|
1.0
|
CAQ
|
I:EXH301
|
3.6
|
35.8
|
1.0
|
CAK
|
I:EXH301
|
3.8
|
37.4
|
1.0
|
C
|
I:HIS110
|
3.9
|
34.2
|
1.0
|
N
|
I:SER111
|
3.9
|
32.7
|
1.0
|
CH2
|
I:TRP117
|
4.0
|
26.1
|
1.0
|
OAG
|
I:EXH301
|
4.1
|
37.5
|
1.0
|
CD1
|
I:ILE109
|
4.2
|
33.6
|
1.0
|
CE2
|
I:TRP117
|
4.3
|
26.4
|
1.0
|
C
|
I:SER111
|
4.5
|
32.7
|
1.0
|
CAP
|
I:EXH301
|
4.5
|
34.5
|
1.0
|
CAZ
|
I:EXH301
|
4.5
|
36.6
|
1.0
|
CAM
|
I:EXH301
|
4.6
|
37.5
|
1.0
|
NE1
|
I:TRP117
|
4.6
|
26.7
|
1.0
|
OH
|
I:TYR98
|
4.7
|
31.3
|
1.0
|
C
|
I:EXH301
|
4.8
|
34.7
|
1.0
|
CE2
|
I:TYR98
|
4.8
|
33.0
|
1.0
|
CZ
|
I:TYR98
|
4.9
|
31.4
|
1.0
|
N
|
I:TYR112
|
4.9
|
31.8
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 6gfy
Go back to
Fluorine Binding Sites List in 6gfy
Fluorine binding site 4 out
of 4 in the Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Pvhl:Elob:Eloc in Complex with Modified VH032 Containing (3R,4S)-3- Fluoro-4-Hydroxyproline (Ligand 14A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
L:F301
b:28.4
occ:1.00
|
FAJ
|
L:EXH301
|
0.0
|
28.4
|
1.0
|
CBD
|
L:EXH301
|
1.4
|
30.2
|
1.0
|
CBC
|
L:EXH301
|
2.4
|
30.8
|
1.0
|
CBF
|
L:EXH301
|
2.4
|
31.5
|
1.0
|
OAI
|
L:EXH301
|
2.6
|
27.8
|
1.0
|
OG
|
L:SER111
|
3.1
|
28.4
|
1.0
|
CB
|
L:SER111
|
3.1
|
30.8
|
1.0
|
CAW
|
L:EXH301
|
3.2
|
31.6
|
1.0
|
CA
|
L:SER111
|
3.3
|
33.6
|
1.0
|
CZ2
|
L:TRP117
|
3.3
|
27.8
|
1.0
|
O
|
L:HIS110
|
3.3
|
39.7
|
1.0
|
NAS
|
L:EXH301
|
3.4
|
28.9
|
1.0
|
NBG
|
L:EXH301
|
3.6
|
33.9
|
1.0
|
CAQ
|
L:EXH301
|
3.6
|
31.4
|
1.0
|
CAK
|
L:EXH301
|
3.9
|
32.3
|
1.0
|
C
|
L:HIS110
|
4.0
|
38.0
|
1.0
|
N
|
L:SER111
|
4.0
|
35.3
|
1.0
|
OAG
|
L:EXH301
|
4.0
|
29.9
|
1.0
|
CH2
|
L:TRP117
|
4.1
|
27.9
|
1.0
|
CD1
|
L:ILE109
|
4.2
|
32.9
|
1.0
|
CE2
|
L:TRP117
|
4.3
|
26.8
|
1.0
|
NE1
|
L:TRP117
|
4.6
|
27.2
|
1.0
|
C
|
L:SER111
|
4.6
|
34.6
|
1.0
|
CAP
|
L:EXH301
|
4.7
|
28.8
|
1.0
|
CAZ
|
L:EXH301
|
4.7
|
30.8
|
1.0
|
CAM
|
L:EXH301
|
4.7
|
33.2
|
1.0
|
C
|
L:EXH301
|
4.8
|
36.2
|
1.0
|
OH
|
L:TYR98
|
4.8
|
28.0
|
1.0
|
CE2
|
L:TYR98
|
4.9
|
28.8
|
1.0
|
N
|
L:TYR112
|
5.0
|
34.0
|
1.0
|
CZ
|
L:TYR98
|
5.0
|
27.7
|
1.0
|
|
Reference:
A.Testa,
X.Lucas,
G.V.Castro,
K.H.Chan,
J.E.Wright,
A.C.Runcie,
M.S.Gadd,
W.T.A.Harrison,
E.J.Ko,
D.Fletcher,
A.Ciulli.
3-Fluoro-4-Hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition By the Vhl E3 Ubiquitin Ligase For Targeted Protein Degradation. J. Am. Chem. Soc. V. 140 9299 2018.
ISSN: ESSN 1520-5126
PubMed: 29949369
DOI: 10.1021/JACS.8B05807
Page generated: Thu Aug 1 20:30:37 2024
|